Systemic sclerosis (SSc) is a rare autoimmune disease characterized by various degrees of skin fibrosis and internal organ involvement. Interstitial lung disease (ILD), or pulmonary fibrosis, is a common complication of SSc, affecting up to 50% of patients. Immunosuppressive drugs are currently used to treat SSc-ILD, particularly in patients with pulmonary symptoms (e.g. shortness of …
At the request of several provincial scleroderma (Scl) associations, I am pleased to provide an overview of recent research carried out under the University of Montreal Scleroderma Research Chair. For the past several years, an advanced program of translational research on Scl is in progress in Montreal at the Research Center of the Centre Hospitalier …
Establishing the Individual Immune Identity Card of Scleroderma Patients Read More »
Supporting people living with scleroderma from around the world by providing rehabilitation and psychosocial online programs free-of-charge. To have access to Spin Online toolkits, login or register at: www.tools.spinsclero.com To read the guide in English press here. To read the guide in French press here.
